ArticleHarm reduction journal2024

Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study.

Björn Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.